Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Still's Disease, Juvenile-Onset”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Post-approval studies (Phase 4)WithdrawnNCT07706868
What this trial is testing

An Efficacy and Safety Study of Subcutaneous Anakinra in Chinese Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still's Disease (AOSD)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (sJIA)Adult Onset Still's Disease (AOSD)
Swedish Orphan Biovitrum
Not applicableStudy completedNCT03276650
What this trial is testing

Admission of Adult-onset Still Disease Patients in the ICU

Who this might be right for
Adult-Onset Still DiseaseCritically Ill
Central Hospital, Nancy, France 45
Large-scale testing (Phase 3)Study completedNCT05001737
What this trial is testing

Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE

Who this might be right for
Macrophage Activation SyndromeSecondary Hemophagocytic LymphohistiocytosisStill Disease+4 more
Swedish Orphan Biovitrum 33
Testing effectiveness (Phase 2)Study completedNCT00094900
What this trial is testing

Interleukin-1 Trap to Treat Autoinflammatory Diseases

Who this might be right for
InflammationFamilial Mediterranean FeverStill's Disease, Adult-Onset
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 11
Large-scale testing (Phase 3)Not Yet RecruitingNCT07625384
What this trial is testing

Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's Disease

Who this might be right for
Still Disease
R-Pharm International, LLC 52
Large-scale testing (Phase 3)Study completedNCT06497491
What this trial is testing

An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease

Who this might be right for
Still's Disease Adult Onset
AO GENERIUM 118
Testing effectiveness (Phase 2)Study completedNCT02398435
What this trial is testing

Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease

Who this might be right for
Still's Disease, Adult-Onset
AB2 Bio Ltd. 23
Not applicableLooking for participantsNCT06339177
What this trial is testing

Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study

Who this might be right for
Lymphohistiocytosis, HemophagocyticSecondary Hemophagocytic LymphohistiocytosisMacrophage Activation Syndrome+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableLooking for participantsNCT03510442
What this trial is testing

Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions

Who this might be right for
Still's Disease, Adult-OnsetSystemic InflammationArthritis+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 2,000
Not applicableEnded earlyNCT00868751
What this trial is testing

Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis

Who this might be right for
Arthritis, Juvenile RheumatoidStill's Disease, Juvenile Onset
Tufts Medical Center 1
Not applicableStudy completedNCT03932344
What this trial is testing

Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Still Disease, Juvenile Onset
Swedish Orphan Biovitrum 306
Not applicableActive Not RecruitingNCT07151157
What this trial is testing

Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease

Who this might be right for
Adult-Onset Still's Disease
Ruijin Hospital 3
Not applicableUnknownNCT03651193
What this trial is testing

Multi-center Registration Study of Adult Onset Still's Disease in Chinese Population

Who this might be right for
Adult Onset Still Disease
Second Xiangya Hospital of Central South University 150
Large-scale testing (Phase 3)Active Not RecruitingNCT05814159
What this trial is testing

Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)

Who this might be right for
Still's Disease, Juvenile OnsetStill's Disease, Adult-Onset
Swedish Orphan Biovitrum 15
Large-scale testing (Phase 3)Study completedNCT00420251
What this trial is testing

Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic ArthritisStill Disease, Juvenile-Onset
Ludwig-Maximilians - University of Munich 50
Not applicableLooking for participantsNCT05927454
What this trial is testing

Acostill ( RaDiCo Cohort) (RaDiCo Acostill)

Who this might be right for
Still DiseaseStill's Disease, Adult-OnsetStill Disease, Juvenile Onset
Institut National de la Santé Et de la Recherche Médicale, France 500
Large-scale testing (Phase 3)WithdrawnNCT05432960
What this trial is testing

Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)

Who this might be right for
Adult-Onset Still's DiseaseAOSD
R-Pharm International, LLC
Not applicableLooking for participantsNCT07191444
What this trial is testing

Firsekibart Versus Anakinra in Adult-Onset Still's Disease

Who this might be right for
Still's Disease, Adult-Onset
Ruijin Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01033656
What this trial is testing

Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study

Who this might be right for
Adult-Onset Still's Disease
University of Helsinki 23
Testing effectiveness (Phase 2)Ended earlyNCT02204293
What this trial is testing

Canakinumab for Treatment of Adult-onset Still's Disease

Who this might be right for
Adult-Onset Still´s Disease
Charite University, Berlin, Germany 36
Next Page